<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-04-29T00:44:23Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7791750" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7791750</identifier>
        <datestamp>2021-01-11</datestamp>
        <setSpec>bmcorhl</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMC Oral Health</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMC Oral Health</journal-id>
              <journal-title-group>
                <journal-title>BMC Oral Health</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1472-6831</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7791750</article-id>
              <article-id pub-id-type="pmcid">PMC7791750</article-id>
              <article-id pub-id-type="pmc-uid">7791750</article-id>
              <article-id pub-id-type="pmid">33413311</article-id>
              <article-id pub-id-type="publisher-id">1359</article-id>
              <article-id pub-id-type="doi">10.1186/s12903-020-01359-1</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Preemptive intravenous iron therapy versus autologous whole blood therapy for early postoperative hemoglobin level in patients undergoing bimaxillary orthognathic surgery: a prospective randomized noninferiority trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chae</surname>
                    <given-names>Min Suk</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lee</surname>
                    <given-names>Mihyun</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Choi</surname>
                    <given-names>Min Ho</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Park</surname>
                    <given-names>Je Uk</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Park</surname>
                    <given-names>Misun</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kim</surname>
                    <given-names>Young Hoon</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Choi</surname>
                    <given-names>Hoon</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Joo</surname>
                    <given-names>Jin</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5141-2652</contrib-id>
                  <name>
                    <surname>Moon</surname>
                    <given-names>Young Eun</given-names>
                  </name>
                  <address>
                    <email>momo0910@catholic.ac.kr</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.411947.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 4224</institution-id><institution>Department of Anesthesiology and Pain Medicine, Seoul St. Mary’s Hospital, College of Medicine, </institution><institution>The Catholic University of Korea, </institution></institution-wrap>222, Banpo-daero, Seocho-gu, Seoul, 06591 Republic of Korea </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.411947.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 4224</institution-id><institution>Department of Oral and Maxillofacial Surgery, Seoul St. Mary’s Hospital, College of Medicine, </institution><institution>The Catholic University of Korea, </institution></institution-wrap>Seoul, Republic of Korea </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.411947.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 4224</institution-id><institution>Department of Biostatistics, Clinical Research Coordinating Center, Catholic Medical Center, </institution><institution>The Catholic University of Korea, </institution></institution-wrap>Seoul, Republic of Korea </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>7</day>
                <month>1</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>7</day>
                <month>1</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2021</year>
              </pub-date>
              <volume>21</volume>
              <elocation-id>16</elocation-id>
              <history>
                <date date-type="received">
                  <day>24</day>
                  <month>8</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>9</day>
                  <month>12</month>
                  <year>2020</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2021</copyright-statement>
                <license license-type="OpenAccess">
                  <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1">Previous studies have reported the efficacy and safety of intravenous (IV) iron therapy during the perioperative period as an alternative and adjunct to allogeneic blood transfusion. Preemptive IV iron therapy provides noninferior hemoglobin levels on postoperative day (POD) 1 compared to autologous whole blood therapy (AWBT) in healthy patients who had undergone bimaxillary orthognathic surgery.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p id="Par2">This was a prospective, patient-randomized, noninferiority trial. After excluding 2 patients, 64 patients were divided into two groups: the IV iron therapy group (patients received IV iron infusion 4 weeks before surgery; <italic>n</italic> = 32) and the AWBT group (2 units of autologous whole blood were collected 4 and 2 weeks before surgery; <italic>n</italic> = 32). The primary outcome was hemoglobin level on POD 1 and the prespecified noninferiority limit was − 1 g/dL.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">Baseline data were comparable, including hemoglobin and iron levels, between the two groups. Immediately before surgery, the levels of hemoglobin, iron, and ferritin were higher in the IV iron group than in the AWBT group. The mean treatment difference (iron group—whole blood group) in hemoglobin level on POD 1 between the two groups was 0.09 (95% CI = − 0.83 to 1.0). As the lower limit of the 95% CI (− 0.83) was higher than the prespecified noninferiority margin (δ = − 1), noninferiority was established. On POD 2, the hemoglobin level became lower in the iron group, which eventually led to greater requirement of allogeneic blood transfusion compared to the whole blood group. However, the iron group did not require allogeneic blood transfusion during or early after surgery, and the whole blood group showed continuously higher incidence of overt iron deficiency compared to the iron group.</p>
                </sec>
                <sec>
                  <title>Conclusion</title>
                  <p id="Par4">As collection of autologous whole blood caused overt iron loss and anemia before surgery and intraoperative transfusion of whole blood was not able to prevent the occurrence of persistent iron deficiency after surgery, IV iron therapy was found to have potential benefits for iron homeostasis and subsequent erythropoiesis in healthy patients early after bimaxillary orthognathic surgery.</p>
                  <p id="Par5"><italic>Trial registration</italic>: Clinical Research Information Service, Republic of Korea, approval number: KCT0003680 on March 27, 2019. <ext-link ext-link-type="uri" xlink:href="https://cris.nih.go.kr/cris/search/search_result_st01_kren.jsp?seq=15769&amp;sLeft=2&amp;ltype=my&amp;rtype=my">https://cris.nih.go.kr/cris/search/search_result_st01_kren.jsp?seq=15769&amp;sLeft=2&amp;ltype=my&amp;rtype=my</ext-link>.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Anemia</kwd>
                <kwd>Iron</kwd>
                <kwd>Ferric carboxymaltose</kwd>
                <kwd>Autologous whole blood</kwd>
                <kwd>Bimaxillary orthognathic surgery</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002648</institution-id>
                      <institution>Catholic University of Korea</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2021</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Background</title>
              <p id="Par18">Bimaxillary orthognathic surgery has been widely performed to correct bimaxillary prognathism or to reposition a mid-facial depression that is frequently associated with a higher risk for large-scale hemorrhage or transfusion requirement during surgery, because of the facial anatomy and surgical approach [<xref ref-type="bibr" rid="CR1">1</xref>]. Strategies to decrease the use of allogeneic blood transfusion include preoperative autologous blood donation and intraoperative hypotensive anesthesia. Autologous whole blood therapy (AWBT) has been encouraged in healthy and young patients because of concerns about allogeneic blood transfusion-related complications, such as infection, allergic or anaphylactic reactions, and alloimmunization [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR4">4</xref>]. In surgeries where a large amount of blood loss is anticipated, such as cardiac or orthopedic surgery, intraoperative transfusion of autologous whole blood favorably enhances postoperative recovery after surgery, including reduced rates of respiratory failure, pneumonia, chest tube output, reoperation for bleeding or infection, and length of hospital stay [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>].</p>
              <p id="Par19">However, in whole blood donation studies [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>], donors have been reported to have lost large amounts of iron on harvesting of a unit of whole blood (500 mL, plus 25 mL for testing), and it requires more than 6 months to restore the iron to the level before donation with a standard diet. After regular blood donation, approximately 25–35% of blood donors become iron deficient, subsequently leading to side effects that can impact health, such as overt anemia, fatigue, neurocognitive changes, pica, and restless legs syndrome [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR11">11</xref>]. Low-dose oral iron intake was reported to contribute to marked reduction of hemoglobin recovery time after donation compared to no oral iron intake, but full recovery of iron and hemoglobin levels took a long time [<xref ref-type="bibr" rid="CR8">8</xref>]. A previous retrospective study suggested that a larger proportion of patients who received intravenous (IV) ferric carboxymaltose, as a dextran-free IV iron complex, experienced effective reversal of acute isovolemic anemia compared to those without treatment [<xref ref-type="bibr" rid="CR12">12</xref>]. Compared to oral iron, high-dose IV iron infusion is also associated with faster and higher replenishment of depleted hemoglobin and iron levels without adverse events [<xref ref-type="bibr" rid="CR13">13</xref>]. Many surgical studies have suggested that IV iron therapy before or after surgery may be efficacious and safe as an alternative and adjunct to allogeneic blood transfusion [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR17">17</xref>]. However, no studies have confirmed this observation in patients who have undergone bimaxillary orthognathic surgery.</p>
              <p id="Par20">We hypothesized that IV iron therapy would provide noninferior hemoglobin levels on postoperative day (POD) 1 compared to AWBT, while reducing postoperative adverse effects of iron depletion and less discomfort/pain during treatment. Therefore, we conducted a randomized, noninferiority clinical trial on healthy patients who had undergone bimaxillary orthognathic surgery.</p>
            </sec>
            <sec id="Sec2">
              <title>Patients and methods</title>
              <sec id="Sec3">
                <title>Ethical considerations</title>
                <p id="Par21">This was a prospective, patient-randomized, noninferiority trial. The protocol was approved by the Institutional Review Board of Seoul St. Mary’s Hospital Ethics Committee (approval no. KC18MESI0583) on December 19, 2018. The study was performed in accordance with the principles of the Declaration of Helsinki. The study protocol was prospectively registered at a publicly accessible clinical registration site that is recognized by the International Committee of Medical Journal Editors (Clinical Research Information Service, Republic of Korea, approval number: KCT0003680) on March 27, 2019. Written informed consent was obtained from all patients at our hospital who were enrolled between March 2019 and May 2020. The study adhered to the Consolidated Standards of Reporting Trials (CONSORT) guidelines (Additional file <xref rid="MOESM1" ref-type="media">1</xref>) and a CONSORT flow chart is provided in Fig. <xref rid="Fig1" ref-type="fig">1</xref>. Additional file <xref rid="MOESM2" ref-type="media">2</xref> presents a summary of our study protocol.<fig id="Fig1"><label>Fig. 1</label><caption><p>Consolidated standards of reporting trials (CONSORT) flow chart</p></caption><graphic xlink:href="12903_2020_1359_Fig1_HTML" id="MO1"/></fig></p>
              </sec>
              <sec id="Sec4">
                <title>Inclusion and exclusion criteria</title>
                <p id="Par22">The inclusion criteria for this study were as follows: age ≥ 20 years; scheduled for elective bimaxillary orthognathic surgery; and American Society of Anesthesiologists (ASA) physical status I or II [<xref ref-type="bibr" rid="CR18">18</xref>]. Exclusion criteria were as follows: hemodynamic instability requiring rescue therapy, such as strong vasopressor infusion (i.e., epinephrine or norepinephrine); ASA physical status III–V; history of iron drug-related side effects, such as allergy; medication history with anticoagulants, such as aspirin, clopidogrel, or warfarin; anemia (i.e., hemoglobin level &lt; 11 g/dL) [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]; and refusal to participate in the study.</p>
              </sec>
              <sec id="Sec5">
                <title>Randomization</title>
                <p id="Par23">The patients were randomly divided into two groups: the IV iron group and the AWBT group. Randomization was performed using sealed, opaque envelopes. An independent colleague randomly grouped the envelopes in blocks of 10 with a 1:1 ratio to produce an equal distribution across the whole study period. The envelopes were stacked and stored. When an enrolled patient arrived in the treatment area, the upper envelope was opened by the attending physicians who performed the treatments, i.e., IV iron infusion or collection of whole blood. In the operating room, the attending anesthesiologist and nurses were aware of the group allocations, but they were not involved in future patient care or data collection.</p>
              </sec>
              <sec id="Sec6">
                <title>Treatment</title>
                <p id="Par24">In the iron group, IV 500 mg ferric carboxymaltose (Ferinject; Vifor Pharma, Glattbrugg, Switzerland) mixed with 100 mL normal saline was administered for 30 min 4 weeks before surgery in accordance with the manufacturer’s instructions.</p>
                <p id="Par25">In the AWBT group, two units of autologous blood were collected, 1 unit at a time with an interval of at least 2 weeks between collections; thus, each unit was collected on 4 and 2 weeks before surgery. The blood volume collected at one time was 320 mL, and therefore, the total amount of whole blood was 640 mL. It was stored in blood bags with a preservation solution of citrate–phosphate-dextrose-adenine at 4 °C until the day of surgery, which is a standard blood management of the hospital [<xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR22">22</xref>]. All collected whole blood was transfused intraoperatively using a warming infusion device.</p>
                <p id="Par26">During and after IV iron supplementation or AWBT, all patients were closely monitored for complications, such as fever (≥ 38 °C), phlebitis, nausea/vomiting, injection-site reactions (i.e., pain or urticaria), dizziness/syncope, hypotension (i.e., SBP &lt; 90 mmHg), tachycardia (i.e., heart rate [HR] &gt; 100 beats/min) or hypersensitivity/allergy.</p>
              </sec>
              <sec id="Sec7">
                <title>Surgery and anesthesia</title>
                <p id="Par27">Surgical technique and anesthetic care were as described previously [<xref ref-type="bibr" rid="CR23">23</xref>]. Briefly, the care of patients was standardized between both groups apart from the treatments applied. Bimaxillary orthognathic surgery, including a bilateral sagittal split osteotomy and a Le Fort I osteotomy, was performed by an experienced surgeon, and balanced general anesthesia was provided without pre-medication by experienced attending anesthesiologists. To reduce surgical bleeding, induced hypotensive anesthesia with a systolic blood pressure (SBP) &lt; 100 mmHg was achieved by intermittent IV boluses of sodium nitroprusside or nicardipine, especially between the beginning of osteotomy and the end of osteosynthesis. Hemodynamic monitoring, including SBP, diastolic blood pressure (DBP), HR, electrocardiogram, pulse oximetry, and end-tidal carbon dioxide pressure, were regularly recorded every 5 min during surgery. Blood lost by surgical hemorrhage was replaced to prevent hypovolemia with one bag (500 mL) of colloid product (6% hydroxyethyl starch, volulyte) in the IV iron group and by 2 units (640 mL) of autologous whole blood in the AWBT group.</p>
                <p id="Par28">Based on the practice guideline [<xref ref-type="bibr" rid="CR19">19</xref>], allogeneic packed red blood cell (PRBC) transfusion was performed at the discretion of the attending anesthesiologists or physicians, when hemoglobin level reached between 6 and 10 g/dL with consideration of potential or actual ongoing hemorrhage, intravascular volume status, organ ischemic signs, or adequacy of cardiopulmonary reserve. These blood products were administered unit-by-unit.</p>
              </sec>
              <sec id="Sec8">
                <title>Clinical variables</title>
                <p id="Par29">Preoperative findings included demographic variables, ASA physical status, vital signs (i.e., SBP, DBP, and HR). Intraoperative findings included total operation duration, average vital signs during surgery, total amount of fluid input, including crystalloid and colloid, hemorrhage, and urine output. Laboratory variables (i.e., hemoglobin, hematocrit, red blood cell [RBC] count, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, iron, ferritin, C-reactive protein, white blood cell count, neutrophil, lymphocyte, and platelet counts, international normalized ratio [INR], activated partial thrombin time, antithrombin III, and fibrinogen) were regularly measured four times: 4 weeks before surgery (baseline), immediately before surgery, and on PODs 1 and 2.</p>
              </sec>
              <sec id="Sec9">
                <title>Outcomes</title>
                <p id="Par30">The primary outcome was the hemoglobin level on POD 1. The secondary outcomes included the levels of inflammatory and coagulation variables on PODs 1 and 2, and changes in blood cell-related variables during POD 2. The incidences of anemia defined as hemoglobin level &lt; 13 g/dL in males and &lt; 12 g/dL in females, low iron level defined as &lt; 50 μg/L, and low ferritin level defined as &lt; 15 ng/mL in males and &lt; 10 ng/mL in females were analyzed in the two groups [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. The degree of discomfort when iron was intravenously infused or whole blood was collected was analyzed using a visual analog scale (VAS; 0 = no discomfort and 10 = the worst discomfort). Surgical complications, such as allogeneic blood transfusion, were analyzed using Clavien–Dindo classification [<xref ref-type="bibr" rid="CR24">24</xref>], and total hospital stay was measured in both groups.</p>
              </sec>
              <sec id="Sec10">
                <title>Statistical analyses</title>
                <p id="Par31">The sample size was calculated based on the primary endpoint according to the noninferiority hypothesis. The predetermined noninferiority limit (δ) was set to a difference in hemoglobin level of − 1 g/dL between the two groups (IV iron group—AWBT group) that was considered clinically acceptable by experts at our institution. Based on preliminary data, a standard deviation (SD) of 1.3 g/dL was assumed for the hemoglobin distribution. With α = 0.05 and power of 90%, 30 patients were required in each group. Assuming a 10% dropout rate, we decided to enroll 33 patients per group. For the primary outcome, the noninferiority of the IV iron therapy was considered if the lower boundary of the two-sided 95% confidence interval (CI) lay above the noninferiority margin of − 1 g/dL [<xref ref-type="bibr" rid="CR25">25</xref>].</p>
                <p id="Par32">Values are expressed as the mean ± SD, median with interquartile range (IQR), or as numbers with percentages. The normality of the distribution of the continuous data was evaluated using the Shapiro–Wilk test. The perioperative findings were compared between the two groups using the unpaired <italic>t</italic> test or the Mann–Whitney <italic>U</italic> test, and Pearson’s <italic>χ</italic><sup>2</sup> test or Fisher’s exact test, as appropriate. Serial changes in RBC-related variables were analyzed using the paired <italic>t</italic> test or Wilcoxon’s signed rank test. All tests were two-sided, and <italic>p</italic> &lt; 0.05 was taken to indicate statistical significance. Statistical analyses were performed using SPSS for Windows (ver. 24.0; IBM Corporation, Armonk, NY) and MedCalc for Windows software (ver. 11.0; MedCalc Software, Ostend, Belgium).</p>
              </sec>
            </sec>
            <sec id="Sec11">
              <title>Results</title>
              <p id="Par33">A total of 68 patients were assessed for eligibility and enrolled in this study. However, two patients refused to participate (<italic>n</italic> = 2). In addition, one patient with suspected malignant hyperthermia (<italic>n</italic> = 1), and one patient in whom nasotracheal intubation failed (<italic>n</italic> = 1), were excluded. Therefore, 64 patients were included in the analyses (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Our study population included healthy patients without comorbidities, such as hypertension, diabetes mellitus, and anemia. There were no adverse events related to IV iron therapy or AWBT, such as fever (≥ 38 °C), phlebitis, nausea/vomiting, injection-site reactions (i.e., pain or urticaria), dizziness/syncope, hypotension, tachycardia, or hypersensitivity/allergy, before surgery. There were no significant differences in preoperative and intraoperative findings between the two groups (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Comparisons of pre- and intraoperative findings between the two groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Group</th><th align="left">Intravenous iron</th><th align="left">Autologous whole blood</th><th align="left" rowspan="2"><italic>p</italic></th></tr><tr><th align="left">n</th><th align="left">32</th><th align="left">32</th></tr></thead><tbody><tr><td align="left" colspan="4">Preoperative findings</td></tr><tr><td align="left"> Sex (male)</td><td align="left">16 (50%)</td><td align="left">17 (53%)</td><td align="left">0.802</td></tr><tr><td align="left"> Age (years)</td><td align="left">21 (20–25)</td><td align="left">21 (20–24)</td><td align="left">0.47</td></tr><tr><td align="left"> Height (cm)</td><td align="left">170.0 (160.7–176.8)</td><td align="left">169.5 (164.0–177.0)</td><td align="left">0.527</td></tr><tr><td align="left"> Weight (kg)</td><td align="left">60.5 (54.0–71.8)</td><td align="left">63.0 (50.0–77.0)</td><td align="left">0.591</td></tr><tr><td align="left"> Body mass index (kg/m<sup>2</sup>)</td><td align="left">22.0 ± 3.9</td><td align="left">22.6 ± 5.3</td><td align="left">0.579</td></tr><tr><td align="left"> ASA physical status I</td><td align="left">32 (100%)</td><td align="left">32 (100%)</td><td align="left">–</td></tr><tr><td align="left" colspan="4">Vital signs</td></tr><tr><td align="left"> Systolic blood pressure (mmHg)</td><td align="left">116 ± 9</td><td align="left">118 ± 13</td><td align="left">0.325</td></tr><tr><td align="left"> Diastolic blood pressure (mmHg)</td><td align="left">72 ± 10</td><td align="left">71 ± 9</td><td align="left">0.664</td></tr><tr><td align="left">Heart rate (beats/min)</td><td align="left">81 ± 12</td><td align="left">81 ± 12</td><td align="left">0.96</td></tr><tr><td align="left" colspan="4">Intraoperative findings</td></tr><tr><td align="left"> Total operation duration (min)</td><td align="left">213 ± 39</td><td align="left">230 ± 35</td><td align="left">0.07</td></tr><tr><td align="left" colspan="4">Average during surgery</td></tr><tr><td align="left"> Systolic blood pressure (mmHg)</td><td align="left">94 (90–97)</td><td align="left">93 (88–99)</td><td align="left">0.851</td></tr><tr><td align="left"> Diastolic blood pressure (mmHg)</td><td align="left">52 (46–55)</td><td align="left">53 (48–59)</td><td align="left">0.371</td></tr><tr><td align="left"> Heart rate (beats/min)</td><td align="left">79 (72–90)</td><td align="left">78 (77–91)</td><td align="left">0.51</td></tr><tr><td align="left" colspan="4"><italic>Total amount of fluid input (mL)</italic></td></tr><tr><td align="left"> Crystalloid (mL)</td><td align="left">1250 (1000–1975)</td><td align="left">1500 (645–2250)</td><td align="left">0.968</td></tr><tr><td align="left"> Colloid (mL)</td><td align="left">650 (500–750)</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left"> Autologous whole blood (mL)</td><td align="left">–</td><td align="left">640 (640–640)</td><td align="left">–</td></tr><tr><td align="left">Hemorrhage (mL)</td><td align="left">900 (500–1138)</td><td align="left">1000 (700–1425)</td><td align="left">0.424</td></tr><tr><td align="left">Urine output (mL)</td><td align="left">150 (120–250)</td><td align="left">215 (50–400)</td><td align="left">0.491</td></tr></tbody></table><table-wrap-foot><p>Values are expressed as mean ± SD, median (interquartile) and number (proportion)</p><p><italic>ASA</italic> American Society of Anesthesiologist</p></table-wrap-foot></table-wrap></p>
              <sec id="Sec12">
                <title>Comparison of perioperative red blood cell-related findings between the two groups</title>
                <p id="Par34">Four weeks before surgery (baseline) (Table <xref rid="Tab2" ref-type="table">2</xref>), hemoglobin, hematocrit, RBC count, red cell index (i.e., MCV, MCH, MCHC), iron, and ferritin were comparable between the two groups. Immediately before surgery, the RBC count, hemoglobin, hematocrit, iron, and ferritin levels were higher in the IV iron group than the AWBT group. On POD 1, the levels of iron and ferritin were higher in the IV iron group than the AWBT group. On POD 2, the IV iron group showed lower hemoglobin level but higher levels of iron and ferritin compared to the AWBT group. Based on the values at 4 weeks before surgery, the levels of hemoglobin, hematocrit, and iron and RBC count decreased gradually during and early after surgery in both groups; however, the ferritin levels were continuously higher in the IV iron group than the AWBT group.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Comparisons of perioperative red blood cell related findings between the two groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Group</th><th align="left">Intravenous iron</th><th align="left">Autologous whole blood</th><th align="left" rowspan="2"><italic>p</italic></th></tr><tr><th align="left">n</th><th align="left">32</th><th align="left">32</th></tr></thead><tbody><tr><td align="left" colspan="4">Four weeks before surgery (baseline)</td></tr><tr><td align="left"> Hemoglobin (g/dL)</td><td char="±" align="char">14.5 ± 1.4</td><td char="±" align="char">14.3 ± 1.4</td><td char="." align="char">0.529</td></tr><tr><td align="left"> Hematocrit (%)</td><td char="±" align="char">42.8 ± 3.8</td><td char="±" align="char">42.5 ± 3.6</td><td char="." align="char">0.79</td></tr><tr><td align="left"> RBC count (× 10<sup>12</sup>/L)</td><td char="±" align="char">4.8 ± 0.4</td><td char="±" align="char">4.7 ± 0.4</td><td char="." align="char">0.491</td></tr><tr><td align="left" colspan="4">Red cell index</td></tr><tr><td align="left"> MCV (fL)</td><td char="±" align="char">89.2 ± 3.5</td><td char="±" align="char">89.3 ± 2.3</td><td char="." align="char">0.831</td></tr><tr><td align="left"> MCH (pg)</td><td char="±" align="char">30.1 ± 1.3</td><td char="±" align="char">30.1 ± 1.0</td><td char="." align="char">0.991</td></tr><tr><td align="left"> MCHC (%)</td><td char="±" align="char">33.9 ± 0.9</td><td char="±" align="char">33.5 ± 0.7</td><td char="." align="char">0.09</td></tr><tr><td align="left"> Iron (μg/dL)</td><td char="±" align="char">128.9 ± 48.6</td><td char="±" align="char">113.3 ± 42.4</td><td char="." align="char">0.176</td></tr><tr><td align="left"> Ferritin (ng/mL)</td><td char="±" align="char">105.7 ± 92.9</td><td char="±" align="char">107.5 ± 77.7</td><td char="." align="char">0.932</td></tr><tr><td align="left" colspan="4">Immediately before surgery</td></tr><tr><td align="left"> Hemoglobin (g/dL)</td><td char="±" align="char">13.5 ± 1.4***</td><td char="±" align="char">12.0 ± 2.0***</td><td char="." align="char"> &lt; 0.001</td></tr><tr><td align="left"> Hematocrit (%)</td><td char="±" align="char">40.2 ± 2.7***</td><td char="±" align="char">35.5 ± 5.5***</td><td char="." align="char"> &lt; 0.001</td></tr><tr><td align="left"> RBC count (× 10<sup>12</sup>/L)</td><td char="±" align="char">4.5 ± 0.4***</td><td char="±" align="char">4.0 ± 0.6***</td><td char="." align="char"> &lt; 0.001</td></tr><tr><td align="left" colspan="4">Red cell index</td></tr><tr><td align="left"> MCV (fL)</td><td char="±" align="char">89.5 ± 3.4</td><td char="±" align="char">89.1 ± 3.7</td><td char="." align="char">0.617</td></tr><tr><td align="left"> MCH (pg)</td><td char="±" align="char">30.1 ± 1.3</td><td char="±" align="char">30.0 ± 1.4</td><td char="." align="char">0.631</td></tr><tr><td align="left"> MCHC (%)</td><td char="±" align="char">33.8 ± 0.8</td><td char="±" align="char">33.6 ± 0.7</td><td char="." align="char">0.401</td></tr><tr><td align="left"> Iron (μg/dL)</td><td char="±" align="char">98.6 ± 33.0***</td><td char="±" align="char">62.2 ± 40.9***</td><td char="." align="char"> &lt; 0.001</td></tr><tr><td align="left"> Ferritin (ng/mL)</td><td char="±" align="char">271.2 ± 156.4**</td><td char="±" align="char">66.3 ± 111.6</td><td char="." align="char"> &lt; 0.001</td></tr><tr><td align="left" colspan="4">Postoperative day 1</td></tr><tr><td align="left"> Hemoglobin (g/dL)</td><td char="±" align="char">10.1 ± 1.9***</td><td char="±" align="char">10.1 ± 1.8***</td><td char="." align="char">0.849</td></tr><tr><td align="left"> Hematocrit (%)</td><td char="±" align="char">30.1 ± 5.5***</td><td char="±" align="char">29.7 ± 4.9***</td><td char="." align="char">0.765</td></tr><tr><td align="left"> RBC count (× 10<sup>12</sup>/L)</td><td char="±" align="char">3.4 ± 0.6***</td><td char="±" align="char">3.4 ± 0.6***</td><td char="." align="char">0.697</td></tr><tr><td align="left" colspan="4">Red cell index</td></tr><tr><td align="left"> MCV (fL)</td><td char="±" align="char">89.0 ± 1.7</td><td char="±" align="char">89.4 ± 3.3</td><td char="." align="char">0.542</td></tr><tr><td align="left"> MCH (pg)</td><td char="±" align="char">30.0 ± 0.7</td><td char="±" align="char">30.0 ± 1.2</td><td char="." align="char">0.829</td></tr><tr><td align="left"> MCHC (%)</td><td char="±" align="char">33.7 ± 0.7</td><td char="±" align="char">33.7 ± 0.8</td><td char="." align="char">0.961</td></tr><tr><td align="left"> Iron (μg/dL)</td><td char="±" align="char">40.6 ± 29.8***</td><td char="±" align="char">22.7 ± 12.1***</td><td char="." align="char">0.002</td></tr><tr><td align="left"> Ferritin (ng/mL)</td><td char="±" align="char">265.2 ± 161.1***</td><td char="±" align="char">102.3 ± 96.2</td><td char="." align="char"> &lt; 0.001</td></tr><tr><td align="left" colspan="4">Postoperative day 2</td></tr><tr><td align="left"> Hemoglobin (g/dL)</td><td char="±" align="char">9.1 ± 1.6***</td><td char="±" align="char">9.9 ± 1.4***</td><td char="." align="char">0.035</td></tr><tr><td align="left"> Hematocrit (%)</td><td char="±" align="char">26.9 ± 4.9***</td><td char="±" align="char">29.4 ± 4.3***</td><td char="." align="char">0.036</td></tr><tr><td align="left"> RBC count (× 10<sup>12</sup>/L)</td><td char="±" align="char">3.0 ± 0.6***</td><td char="±" align="char">3.3 ± 0.5***</td><td char="." align="char">0.022</td></tr><tr><td align="left" colspan="4">Red cell index</td></tr><tr><td align="left"> MCV (fL)</td><td char="±" align="char">89.8 ± 2.5</td><td char="±" align="char">89.9 ± 3.5</td><td char="." align="char">0.823</td></tr><tr><td align="left"> MCH (pg)</td><td char="±" align="char">30.4 ± 1.0</td><td char="±" align="char">29.9 ± 1.3</td><td char="." align="char">0.081</td></tr><tr><td align="left"> MCHC (%)</td><td char="±" align="char">33.9 ± 0.5</td><td char="±" align="char">33.7 ± 0.7</td><td char="." align="char">0.433</td></tr><tr><td align="left"> Iron (μg/dL)</td><td char="±" align="char">63.0 ± 26.4***</td><td char="±" align="char">41.4 ± 22.9***</td><td char="." align="char">0.001</td></tr><tr><td align="left"> Ferritin (ng/mL)</td><td char="±" align="char">281.8 ± 150.3***</td><td char="±" align="char">107.3 ± 93.5</td><td char="." align="char"> &lt; 0.001</td></tr></tbody></table><table-wrap-foot><p>Values are expressed as mean ± SD and number (proportion)</p><p><italic>RBC</italic> red blood cell, <italic>MCV</italic> mean corpuscular volume, <italic>MCH</italic> mean corpuscular hemoglobin, <italic>HCHC</italic> mean corpuscular hemoglobin concentration</p><p><sup>*</sup><italic>p</italic> &lt; 0.05 based on the level at 4 weeks before surgery (baseline)</p><p><sup>**</sup><italic>p</italic> &lt; 0.01 based on the level at 4 weeks before surgery (baseline)</p><p><sup>***</sup><italic>p</italic> &lt; 0.001 based on the level at 4 weeks before surgery (baseline)</p></table-wrap-foot></table-wrap></p>
                <p id="Par35">The incidence of anemia immediately before surgery was lower in the IV iron group than the AWBT group (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). The incidences of low iron level immediately before surgery and on PODs 1 and 2 were lower in the iron group than the AWBT group. The incidence of low ferritin level immediately before surgery was lower in the iron group than the AWBT group.<fig id="Fig2"><label>Fig. 2</label><caption><p>Comparison of proportion of patients with <bold>a</bold> anemia, and low levels of <bold>b</bold> iron and <bold>c</bold> ferritin at 4 weeks before surgery, immediately before surgery, and on postoperative days 1 and 2 in patients with IV iron therapy (<italic>n</italic> = 32) and autologous whole blood therapy (<italic>n</italic> = 32). Values are expressed as number and proportion (%)</p></caption><graphic xlink:href="12903_2020_1359_Fig2_HTML" id="MO2"/></fig></p>
                <p id="Par36">Based on the values at 4 weeks before surgery (baseline), changes in hemoglobin levels immediately before surgery were lower, but these changes on POD 2 were higher in the IV iron group than the AWBT group (Table <xref rid="Tab3" ref-type="table">3</xref>). The change in iron level on POD 1 was lower in the iron group than the AWBT group. Changes in ferritin levels immediately before surgery and on PODs 1 and 2 were higher in the iron group than the AWBT group.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Comparison of perioperative changes in hemoglobin, iron, and ferritin levels based on the values at 4 weeks before surgery (baseline) between the two groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Group</th><th align="left">Intravenous iron</th><th align="left">Autologous whole blood</th><th align="left" rowspan="2"><italic>p</italic></th></tr><tr><th align="left">n</th><th align="left">32</th><th align="left">32</th></tr></thead><tbody><tr><td align="left" colspan="4">Change of hemoglobin level (%)</td></tr><tr><td align="left"> Immediately before surgery</td><td char="±" align="char"> − 6.47 ± 5.51</td><td char="±" align="char"> − 16.36 ± 10.27</td><td char="." align="char"> &lt; 0.001</td></tr><tr><td align="left"> Postoperative day 1</td><td char="±" align="char"> − 29.92 ± 11.21</td><td char="±" align="char"> − 29.73 ± 8.38</td><td char="." align="char">0.938</td></tr><tr><td align="left"> Postoperative day 2</td><td char="±" align="char"> − 37.18 ± 10.07</td><td char="±" align="char"> − 30.64 ± 7.02</td><td char="." align="char">0.004</td></tr><tr><td align="left" colspan="4">Change of iron level (%)</td></tr><tr><td align="left"> Immediately before surgery</td><td char="±" align="char"> − 14.78 ± 39.97</td><td char="±" align="char"> − 35.95 ± 54.82</td><td char="." align="char">0.082</td></tr><tr><td align="left"> Postoperative day 1</td><td char="±" align="char"> − 65.9 ± 23.04</td><td char="±" align="char"> − 76.26 ± 15.57</td><td char="." align="char">0.04</td></tr><tr><td align="left"> Postoperative day 2</td><td char="±" align="char"> − 43.57 ± 33.42</td><td char="±" align="char"> − 56.27 ± 35.9</td><td char="." align="char">0.148</td></tr><tr><td align="left" colspan="4">Change of ferritin level (%)</td></tr><tr><td align="left"> Immediately before surgery</td><td char="±" align="char">273.28 ± 324.54</td><td char="±" align="char"> − 20.53 ± 213.09</td><td char="." align="char"> &lt; 0.001</td></tr><tr><td align="left"> Postoperative day 1</td><td char="±" align="char">261.35 ± 281.57</td><td char="±" align="char">45.38 ± 195.97</td><td char="." align="char">0.001</td></tr><tr><td align="left"> Postoperative day 2</td><td char="±" align="char">309.07 ± 344.98</td><td char="±" align="char">53.55 ± 188.3</td><td char="." align="char">0.001</td></tr></tbody></table><table-wrap-foot><p>Values are expressed as mean ± SD</p><p>Changes (%) are defined as ((each value—value at 4 weeks before surgery)/value at 4 weeks before surgery) × 100</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec13">
                <title>Noninferiority of differences in hemoglobin levels before, during, and after surgery between the two groups</title>
                <p id="Par37">The mean treatment difference (IV iron group—AWBT group) in the hemoglobin level on POD 1 between the two groups was 0.09 (95% CI = − 0.83 to 1.0) (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). As the lower limit of the 95% CI (− 0.83) was higher than the prespecified noninferiority margin (δ = − 1), noninferiority was established. In addition, the mean treatment differences in hemoglobin levels between the two groups were as follows: immediately before surgery, 1.59 (95% CI = 0.73 to 2.44); and on POD 2, − 0.81 (95% CI = − 1.55 to − 0.06).<fig id="Fig3"><label>Fig. 3</label><caption><p>Noninferiority diagram of differences in hemoglobin levels between intravenous iron and autologous whole blood therapy groups immediately before surgery, and on postoperative days 1 and 2. A noninferiority margin (δ) indicates &gt; Δ = − 1. Circles indicate mean hemoglobin differences and error bars indicate the 95% CIs of the differences between the two groups</p></caption><graphic xlink:href="12903_2020_1359_Fig3_HTML" id="MO3"/></fig></p>
              </sec>
              <sec id="Sec14">
                <title>Comparison of other postoperative findings between the two groups</title>
                <p id="Par38">The inflammatory findings before, during, and after surgery were comparable between the two groups (Additional file <xref rid="MOESM3" ref-type="media">3</xref>). With regard to coagulation findings, the platelet, antithrombin III, and fibrinogen levels on POD 1 were higher and the INR was more prolonged in the IV iron group than the AWBT group. On POD 2, the platelet and antithrombin III levels were lower and the INR were more prolonged in the IV iron group than the AWBT group. However, postoperative coagulation values were within the respective normal ranges in both groups [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR26">26</xref>].</p>
                <p id="Par39">Although all patients experienced a mild degree (≤ 3 VAS) of discomfort or pain in both treatment groups, the median (IQR) VAS was lower in the IV iron group than the AWBT group (0 [0–0] vs. 2 [], respectively; <italic>p</italic> &lt; 0.001). The proportion of patients with Clavien–Dindo classification II related to requirement of allogeneic PRBC transfusion on POD 2 was higher in the IV iron group than the AWBT group (<italic>n</italic> = 8, 25.0% vs. <italic>n</italic> = 1, 3.1%, respectively; <italic>p</italic> = 0.026). However, the total length of hospital stay was comparable between the two groups (2.5 ± 0.6 vs. 2.4 ± 0.5 days, respectively; <italic>p</italic> = 0.269).</p>
              </sec>
              <sec id="Sec15">
                <title>Discussion</title>
                <p id="Par40">We found that IV iron therapy provided noninferior hemoglobin levels compared to AWBT after bimaxillary orthognathic surgery in the first 24 h postoperatively. In the operating room, the patients with IV iron therapy showed higher levels of hemoglobin, iron, and ferritin than those with AWBT and they did not require allogeneic blood transfusion during surgery. In addition, the patients with IV iron infusion showed less discomfort/pain during the treatment compared to those from whom whole blood was harvested. However, the hemoglobin level in the IV iron group decreased markedly thereafter, and on the second day after surgery led to a greater need for blood transfusion.</p>
                <p id="Par41">Many observational studies have suggested benefits of early IV iron therapy that lead to regaining oxygen carrying capacity and improvement of organ functional recovery and quality of life in critically ill patients, such as those with kidney or heart failure [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Hemorrhage is one of the most common complications during surgery that causes acute loss of oxygen delivery capability and components, such as hemoglobin and iron. These losses are markedly aggravated when lost blood is replaced with fluid, and eventually have a negative impact on short- and long-term prognostic outcomes. In patients at risk for iron storage shortage or overt anemia, early IV iron therapy helps build up the levels of hemoglobin and iron preoperatively and reduce the need for blood transfusion intraoperatively [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Piednoir et al. [<xref ref-type="bibr" rid="CR10">10</xref>] reported that patients with iron deficiency but without anemia are associated with larger PRBC transfusions and poorer physical fatigue scores than those without iron deficiency or anemia after cardiac surgery. In Kim et al. [<xref ref-type="bibr" rid="CR30">30</xref>], patients who received 500 mg or 1000 mg IV ferric carboxymaltose (ferric carboxymaltose group) had a better hemoglobin response, as determined by a hemoglobin increase ≥ 2 g/dL from baseline, and greater improvements in iron-related variables (i.e., serum levels of ferritin and levels of transferrin saturation) 12 weeks after gastrectomy than patients who received IV normal saline (placebo group). The requirement of alternative anemia care, including oral iron or transfusion, was lower in the ferric carboxymaltose group than in the placebo group. In addition, the occurrence and aggravation of anemia were affected by active and persistent inflammatory response related to conditions of absolute and/or functional iron deficiency after surgery. As these conditions of iron deficiency were hardly corrected by the administration of oral iron due to a decrease in gastrointestinal iron absorption related to surgical stimuli, IV iron administration seemed to be an efficient and safe means of enhancing recovery from anemia and attenuating the requirement for allogeneic blood transfusion with very few severe side effects, such as drug allergy [<xref ref-type="bibr" rid="CR17">17</xref>]. In a study of anemic critically ill patients, Iperen et al. [<xref ref-type="bibr" rid="CR31">31</xref>] suggested that the regime with IV iron sucrose at dose of 20 mg/day improved systemic inflammatory response with reduction in C-reactive protein level, and contributed to lowering both the requirement for blood transfusion and mortality rate.</p>
                <p id="Par42">However, commonly reported adverse events, associated with IV ferric carboxymaltose include injection site reactions, phlebitis, fever, nausea, constipation, headache, and diarrhea; reactions are mild to moderate in severity. In a large multicenter trial, the reported ferric carboxymaltose-related complications were injection site reactions (2.3%) and urticaria (2.3%), but there were no serious complications, such as hypersensitivity or anaphylactic reactions [<xref ref-type="bibr" rid="CR30">30</xref>]. Among patients with chronic kidney dysfunction who received a higher dose of IV ferric carboxymaltose, two showed mild hypersensitivity that did not require hospitalization [<xref ref-type="bibr" rid="CR32">32</xref>]. In women with a history of heavy uterine bleeding, an unexpected side-effect—hypophosphatemia—was reported, but no patients were symptomatic. Although this side-effect is not fully understood, it may be related to an increase in the phosphaturic hormone fibroblast growth factor-23 [<xref ref-type="bibr" rid="CR33">33</xref>]. Although previous studies and our results demonstrate the safety of IV ferric carboxymaltose, there are still theoretical mechanisms by which IV iron could exacerbate cardiovascular injury due to its effect on oxidative stress, and potential concerns related to IV iron worsening infections and hypersensitivity [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR32">32</xref>–<xref ref-type="bibr" rid="CR34">34</xref>].</p>
                <p id="Par43">In contrast to previous studies, our findings did not show positive postoperative results of IV iron therapy, which may be explained by differences in patient condition and surgical settings. In many studies that have reported favorable outcomes of IV iron therapy, the patients were anemic or iron-deficient before surgery, with chronic and critical illnesses, such as malignancy, and older age. These factors disturbed iron balance and decreased oxygen delivery capability of hemoglobin. The correction of iron deficiency by IV iron infusion facilitated the recovery of iron-containing oxygen transport carriers, such as suitable structure and concentration of hemoglobin [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR28">28</xref>–<xref ref-type="bibr" rid="CR30">30</xref>]. However, our patients were healthy, young, and did not have any comorbidities or abnormal laboratory variables preoperatively. Prophylactic IV iron treatment in these patients may not be as effective as in patients with existing iron-deficient anemia. In Oh et al. [<xref ref-type="bibr" rid="CR35">35</xref>], the incidence of allogeneic blood transfusion was significantly lower in patients who received preoperatively collected autologous blood than in patients who did not. This difference was predominantly greater in patients with a preoperative hemoglobin level &lt; 14 g/dL than ≥ 14 g/dL. However, the rate of discarding collected autologous blood was as high as 38.5% in patients with preoperative hemoglobin level ≥ 14 g/dL compared to the rate of 10.5% in those with a level &lt; 14 g/dL (<italic>p</italic> &lt; 0.0001). Therefore, appropriately raising the level of hemoglobin before surgery seems to be the cornerstone to successfully reducing the need for blood transfusion and the collection of large amounts of the patient’s own whole blood [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. However, immediate recovery of hemoglobin level after surgery is not possible with IV iron administration, because production and maturation of hemoglobin derived from stored iron, such as ferritin, require several weeks to months [<xref ref-type="bibr" rid="CR38">38</xref>]. Therefore, although patients who received AWBT had a higher incidence of anemia and lower levels of iron and ferritin before and during surgery than patients with IV iron therapy, the active response to regain hemoglobin level after intraoperative hemorrhage may be better in such patients.</p>
                <p id="Par44">The AWBT is a technique in which the patient’s own blood is collected and saved for a period of time before surgery, and reinfused during surgery. Repeated blood donations before surgery induce bone marrow cell proliferation and erythrocyte regeneration, which that accelerates hematopoietic function and postoperative recovery. These changes may decrease the requirement for allogeneic blood transfusion related to immunoreaction and infectious vulnerability [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. However, the period from the first emergence of erythroid progenitor cells in the bone marrow to the emergence of mature erythrocytes in the peripheral blood is up to 4 weeks long, and erythrocyte regeneration in one withdrawn red blood cell unit takes up to 6 months [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR9">9</xref>]. Additionally, because of the limitations of conventional blood storage techniques using citrate–phosphate-dextrose-adenine solution for blood preservation and the red cell storage-life of 35 days at 4 °C, the AWBT should commence 4–5 weeks prior to surgery, allowing the collection of whole blood, and the last donation should take place at least 48–72 h before surgery to allow for equilibration of blood volume [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. In patients who received the AWBT, the hematocrit and iron-related components significantly decreased from the initial level before AWBT to the level immediately before surgery [<xref ref-type="bibr" rid="CR9">9</xref>]. Therefore, the AWBT is suitable primarily for young and robust patients without anemia scheduled for elective surgery in 4–5 weeks.</p>
                <p id="Par45">This study had some limitations. First, although IV iron infusion was performed 4 weeks before surgery, RBC synthesis may not function sufficiently during this period. Further studies are required to investigate the optimal interval between IV iron therapy and surgery in patients without overt anemia scheduled for surgery. Second, we were not able to determine the optimal dose of IV iron for prevention or compensation of the surgical loss in healthy patients, because there have been few studies on the relationship between type of surgery or bleeding and iron loss. Finally, we did not measure the long-term postoperative changes in hemoglobin, iron, and ferritin levels, such as those occurring over weeks to months. However, based on previously reported findings [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR43">43</xref>], sufficient amounts of iron and ferritin in patients with IV iron therapy may play roles in restoring appropriate hemoglobin levels postoperatively. However, our study is the first to perform a non-inferiority comparison of the effect of a novel IV iron drug (ferric carboxymaltose) and conventional blood salvage therapy (autologous whole blood donation) on the postoperative hemoglobin level in robust young patients undergoing bimaxillary orthognathic surgery. Although previous studies suggested IV iron therapy ensured better oxygen-carrying capacity, those studies were limited by comparison to normal saline therapy as a control group.</p>
              </sec>
            </sec>
            <sec id="Sec16">
              <title>Conclusion</title>
              <p id="Par46">Although the levels of hemoglobin, iron, and ferritin were better immediately before surgery in healthy patients who received preoperative IV iron therapy, this treatment did not seem to be effective for significantly raising hemoglobin levels or reducing the low hemoglobin level-based requirement for allogeneic blood transfusion compared to AWBT after surgical hemorrhage and injury. However, as collection of autologous whole blood caused overt iron loss and anemia before surgery and intraoperative transfusion of the whole blood was unable to prevent the occurrence of persistent iron deficiency after surgery, IV iron therapy has potential benefits for iron homeostasis and subsequent erythropoiesis in healthy patients early after bimaxillary orthognathic surgery. Therefore, preoperative IV iron therapy alone may be equally effective in ensuring a sufficient hemoglobin level on POD 1 compared to therapy with intraoperative infusion of autologous whole blood harvested before surgery, but the non-inferiority results did not persist after POD 1. Appropriately powered randomized controlled trials examining the effects of IV iron with/without autologous whole blood and subsequent long-term outcome after bimaxillary orthognathic surgery are required.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Information</title>
              <sec id="Sec17">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="12903_2020_1359_MOESM1_ESM.doc">
                      <caption>
                        <p><bold>Additional file 1.</bold> Consolidated Standards of Reporting Trials (CONSORT) guidelines.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM2">
                    <media xlink:href="12903_2020_1359_MOESM2_ESM.docx">
                      <caption>
                        <p><bold>Additional file 2.</bold> Summary of our bimaxillary orthognathic surgery protocol.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM3">
                    <media xlink:href="12903_2020_1359_MOESM3_ESM.docx">
                      <caption>
                        <p><bold>Additional file 3.</bold> Comparison of perioperative inflammatory and coagulation findings between the two groups.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>IV</term>
                  <def>
                    <p id="Par6">Intravenous</p>
                  </def>
                </def-item>
                <def-item>
                  <term>POD</term>
                  <def>
                    <p id="Par7">Postoperative day</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ASA</term>
                  <def>
                    <p id="Par8">American Society of Anesthesiologists</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SBP</term>
                  <def>
                    <p id="Par9">Systolic blood pressure</p>
                  </def>
                </def-item>
                <def-item>
                  <term>DBP</term>
                  <def>
                    <p id="Par10">Diastolic blood pressure</p>
                  </def>
                </def-item>
                <def-item>
                  <term>HR</term>
                  <def>
                    <p id="Par11">Heart rate</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PRBC</term>
                  <def>
                    <p id="Par12">Packed red blood cell</p>
                  </def>
                </def-item>
                <def-item>
                  <term>BMI</term>
                  <def>
                    <p id="Par13">Body mass index</p>
                  </def>
                </def-item>
                <def-item>
                  <term>RBC</term>
                  <def>
                    <p id="Par14">Red blood cell</p>
                  </def>
                </def-item>
                <def-item>
                  <term>INR</term>
                  <def>
                    <p id="Par15">International normalized ratio</p>
                  </def>
                </def-item>
                <def-item>
                  <term>VAS</term>
                  <def>
                    <p id="Par16">Visual analogue scale</p>
                  </def>
                </def-item>
                <def-item>
                  <term>IQR</term>
                  <def>
                    <p id="Par17">Interquartile</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher's Note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <sec>
              <title>Supplementary Information</title>
              <p>The online version contains supplementary material available at 10.1186/s12903-020-01359-1.</p>
            </sec>
            <ack>
              <title>Acknowledgements</title>
              <p>The authors wish to acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2020.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Authors’ contributions</title>
              <p>M.S.C. and Y.E.M. designed the study, wrote the manuscript, and analyzed and interpreted the data. M.S.C., M.L., H.C., J.J., and Y.E.M. collected the data and provided critical comments. M.P. and Y.H.K. performed the statistical analyses. All authors revised the manuscript critically for important intellectual content. All authors read and approved the final manuscript.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>The authors wish to acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2020.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Availability of data and materials</title>
              <p>The datasets used and/or analysed during this study are available from the corresponding author on reasonable request.</p>
            </notes>
            <notes id="FPar1">
              <title>Ethics approval and consent to participate</title>
              <p id="Par47">This was a prospective, patient-randomized, noninferiority trial. The protocol was approved by the Institutional Review Board of Seoul St. Mary’s Hospital Ethics Committee (Approval No. KC18MESI0583) on December 19, 2018. The study was performed in accordance with the principles of the Declaration of Helsinki. The study protocol was prospectively registered at a publicly accessible clinical registration site that is recognized by the International Committee of Medical Journal Editors (Clinical Research Information Service, Republic of Korea, approval number: KCT0003680) on March 27, 2019. Written informed consent was obtained from all patients at our hospital who were enrolled between March 2019 and May 2020. The study adhered to the Consolidated Standards of Reporting Trials (CONSORT) guidelines (Additional file <xref rid="MOESM1" ref-type="media">1</xref>) and a CONSORT flow chart is provided in Fig. <xref rid="Fig1" ref-type="fig">1</xref>. Additional file <xref rid="MOESM2" ref-type="media">2</xref> presents a summary of our study protocol.</p>
            </notes>
            <notes id="FPar2">
              <title>Consent for publication</title>
              <p id="Par48">Not applicable.</p>
            </notes>
            <notes id="FPar3" notes-type="COI-statement">
              <title>Competing interests</title>
              <p id="Par49">The authors have no conflicts of interest to declare.</p>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Moenning</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Bussard</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Lapp</surname>
                      <given-names>TH</given-names>
                    </name>
                    <name>
                      <surname>Garrison</surname>
                      <given-names>BT</given-names>
                    </name>
                  </person-group>
                  <article-title>Average blood loss and the risk of requiring perioperative blood transfusion in 506 orthognathic surgical procedures</article-title>
                  <source>J Oral Maxillofac Surgery</source>
                  <year>1995</year>
                  <volume>53</volume>
                  <issue>8</issue>
                  <fpage>880</fpage>
                  <lpage>883</lpage>
                  <pub-id pub-id-type="doi">10.1016/0278-2391(95)90273-2</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Neuwirth</surname>
                      <given-names>BR</given-names>
                    </name>
                    <name>
                      <surname>White</surname>
                      <given-names>RP</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>Collins</surname>
                      <given-names>ML</given-names>
                    </name>
                    <name>
                      <surname>Phillips</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Recovery following orthognathic surgery and autologous blood transfusion</article-title>
                  <source>Int J Adult Orthodont Orthognathic Surg</source>
                  <year>1992</year>
                  <volume>7</volume>
                  <issue>4</issue>
                  <fpage>221</fpage>
                  <lpage>228</lpage>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Marciani</surname>
                      <given-names>RD</given-names>
                    </name>
                    <name>
                      <surname>Dickson</surname>
                      <given-names>LG</given-names>
                    </name>
                  </person-group>
                  <article-title>Autologous transfusion in orthognathic surgery</article-title>
                  <source>J Oral Maxillofac Surg</source>
                  <year>1985</year>
                  <volume>43</volume>
                  <issue>3</issue>
                  <fpage>201</fpage>
                  <lpage>204</lpage>
                  <pub-id pub-id-type="doi">10.1016/0278-2391(85)90160-0</pub-id>
                  <?supplied-pmid 3855990?>
                  <pub-id pub-id-type="pmid">3855990</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ervens</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Marks</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Hechler</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Plath</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Hansen</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Hoffmeister</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of induced hypotensive anaesthesia vs isovolaemic haemodilution on blood loss and transfusion requirements in orthognathic surgery: a prospective, single-blinded, randomized, controlled clinical study</article-title>
                  <source>Int J Oral Maxillofac Surg</source>
                  <year>2010</year>
                  <volume>39</volume>
                  <issue>12</issue>
                  <fpage>1168</fpage>
                  <lpage>1174</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ijom.2010.09.003</pub-id>
                  <?supplied-pmid 20961738?>
                  <pub-id pub-id-type="pmid">20961738</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Newman</surname>
                      <given-names>ET</given-names>
                    </name>
                    <name>
                      <surname>Watters</surname>
                      <given-names>TS</given-names>
                    </name>
                    <name>
                      <surname>Lewis</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Jennings</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Wellman</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Attarian</surname>
                      <given-names>DE</given-names>
                    </name>
                    <name>
                      <surname>Grant</surname>
                      <given-names>SA</given-names>
                    </name>
                    <name>
                      <surname>Green</surname>
                      <given-names>CL</given-names>
                    </name>
                    <name>
                      <surname>Vail</surname>
                      <given-names>TP</given-names>
                    </name>
                    <name>
                      <surname>Bolognesi</surname>
                      <given-names>MP</given-names>
                    </name>
                  </person-group>
                  <article-title>Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty</article-title>
                  <source>J Bone Joint Surg Am</source>
                  <year>2014</year>
                  <volume>96</volume>
                  <issue>4</issue>
                  <fpage>279</fpage>
                  <lpage>284</lpage>
                  <pub-id pub-id-type="doi">10.2106/JBJS.L.01041</pub-id>
                  <?supplied-pmid 24553883?>
                  <pub-id pub-id-type="pmid">24553883</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Avgerinos</surname>
                      <given-names>DV</given-names>
                    </name>
                    <name>
                      <surname>DeBois</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Salemi</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Blood conservation strategies in cardiac surgery: more is better</article-title>
                  <source>Eur J Cardio-thoracic Surg</source>
                  <year>2014</year>
                  <volume>46</volume>
                  <issue>5</issue>
                  <fpage>865</fpage>
                  <lpage>870</lpage>
                  <pub-id pub-id-type="doi">10.1093/ejcts/ezt661</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cable</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Brambilla</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Glynn</surname>
                      <given-names>SA</given-names>
                    </name>
                    <name>
                      <surname>Kleinman</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Mast</surname>
                      <given-names>AE</given-names>
                    </name>
                    <name>
                      <surname>Spencer</surname>
                      <given-names>BR</given-names>
                    </name>
                    <name>
                      <surname>Stone</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Kiss</surname>
                      <given-names>JE</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of iron supplementation on iron stores and total body iron after whole blood donation</article-title>
                  <source>Transfusion</source>
                  <year>2016</year>
                  <volume>56</volume>
                  <issue>8</issue>
                  <fpage>2005</fpage>
                  <lpage>2012</lpage>
                  <pub-id pub-id-type="doi">10.1111/trf.13659</pub-id>
                  <?supplied-pmid 27232535?>
                  <pub-id pub-id-type="pmid">27232535</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kiss</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Brambilla</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Glynn</surname>
                      <given-names>SA</given-names>
                    </name>
                    <name>
                      <surname>Mast</surname>
                      <given-names>AE</given-names>
                    </name>
                    <name>
                      <surname>Spencer</surname>
                      <given-names>BR</given-names>
                    </name>
                    <name>
                      <surname>Stone</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Kleinman</surname>
                      <given-names>SH</given-names>
                    </name>
                    <name>
                      <surname>Cable</surname>
                      <given-names>RG</given-names>
                    </name>
                  </person-group>
                  <article-title>Oral iron supplementation after blood donation: a randomized clinical trial</article-title>
                  <source>JAMA</source>
                  <year>2015</year>
                  <volume>313</volume>
                  <issue>6</issue>
                  <fpage>575</fpage>
                  <lpage>583</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2015.119</pub-id>
                  <?supplied-pmid 25668261?>
                  <pub-id pub-id-type="pmid">25668261</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kiss</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Vassallo</surname>
                      <given-names>RR</given-names>
                    </name>
                  </person-group>
                  <article-title>How do we manage iron deficiency after blood donation?</article-title>
                  <source>Br J Haematol</source>
                  <year>2018</year>
                  <volume>181</volume>
                  <issue>5</issue>
                  <fpage>590</fpage>
                  <lpage>603</lpage>
                  <pub-id pub-id-type="doi">10.1111/bjh.15136</pub-id>
                  <?supplied-pmid 29767836?>
                  <pub-id pub-id-type="pmid">29767836</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Piednoir</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Allou</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Driss</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Longrois</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Philip</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Beaumont</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Montravers</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Lasocki</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Preoperative iron deficiency increases transfusion requirements and fatigue in cardiac surgery patients: a prospective observational study</article-title>
                  <source>Eur J Anaesthesiol</source>
                  <year>2011</year>
                  <volume>28</volume>
                  <issue>11</issue>
                  <fpage>796</fpage>
                  <lpage>801</lpage>
                  <pub-id pub-id-type="doi">10.1097/EJA.0b013e32834ad97b</pub-id>
                  <?supplied-pmid 21885979?>
                  <pub-id pub-id-type="pmid">21885979</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Toy</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Feiner</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Viele</surname>
                      <given-names>MK</given-names>
                    </name>
                    <name>
                      <surname>Watson</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Yeap</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Weiskopf</surname>
                      <given-names>RB</given-names>
                    </name>
                  </person-group>
                  <article-title>Fatigue during acute isovolemic anemiain healthy, resting humans</article-title>
                  <source>Transfusion</source>
                  <year>2000</year>
                  <volume>40</volume>
                  <issue>4</issue>
                  <fpage>457</fpage>
                  <lpage>460</lpage>
                  <pub-id pub-id-type="doi">10.1046/j.1537-2995.2000.40040457.x</pub-id>
                  <?supplied-pmid 10773059?>
                  <pub-id pub-id-type="pmid">10773059</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yoon</surname>
                      <given-names>HM</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>YW</given-names>
                    </name>
                    <name>
                      <surname>Nam</surname>
                      <given-names>BH</given-names>
                    </name>
                    <name>
                      <surname>Reim</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Eom</surname>
                      <given-names>BW</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>JY</given-names>
                    </name>
                    <name>
                      <surname>Ryu</surname>
                      <given-names>KW</given-names>
                    </name>
                  </person-group>
                  <article-title>Intravenous iron supplementation may be superior to observation in acute isovolemic anemia after gastrectomy for cancer</article-title>
                  <source>World J Gastroenterol</source>
                  <year>2014</year>
                  <volume>20</volume>
                  <issue>7</issue>
                  <fpage>1852</fpage>
                  <lpage>1857</lpage>
                  <pub-id pub-id-type="doi">10.3748/wjg.v20.i7.1852</pub-id>
                  <?supplied-pmid 24587663?>
                  <pub-id pub-id-type="pmid">24587663</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Keating</surname>
                      <given-names>GM</given-names>
                    </name>
                  </person-group>
                  <article-title>Ferric carboxymaltose: a review of its use in iron deficiency</article-title>
                  <source>Drugs</source>
                  <year>2015</year>
                  <volume>75</volume>
                  <issue>1</issue>
                  <fpage>101</fpage>
                  <lpage>127</lpage>
                  <pub-id pub-id-type="doi">10.1007/s40265-014-0332-3</pub-id>
                  <?supplied-pmid 25428711?>
                  <pub-id pub-id-type="pmid">25428711</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Serrano-Trenas</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Ugalde</surname>
                      <given-names>PF</given-names>
                    </name>
                    <name>
                      <surname>Cabello</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Chofles</surname>
                      <given-names>LC</given-names>
                    </name>
                    <name>
                      <surname>Lazaro</surname>
                      <given-names>PS</given-names>
                    </name>
                    <name>
                      <surname>Benitez</surname>
                      <given-names>PC</given-names>
                    </name>
                  </person-group>
                  <article-title>Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial</article-title>
                  <source>Transfusion</source>
                  <year>2011</year>
                  <volume>51</volume>
                  <issue>1</issue>
                  <fpage>97</fpage>
                  <lpage>104</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1537-2995.2010.02769.x</pub-id>
                  <?supplied-pmid 20630042?>
                  <pub-id pub-id-type="pmid">20630042</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Anker</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Comin Colet</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Filippatos</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Willenheimer</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Dickstein</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Drexler</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Lüscher</surname>
                      <given-names>TF</given-names>
                    </name>
                    <name>
                      <surname>Bart</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Banasiak</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Niegowska</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Ferric carboxymaltose in patients with heart failure and iron deficiency</article-title>
                  <source>N Engl J Med</source>
                  <year>2009</year>
                  <volume>361</volume>
                  <issue>25</issue>
                  <fpage>2436</fpage>
                  <lpage>2448</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa0908355</pub-id>
                  <?supplied-pmid 19920054?>
                  <pub-id pub-id-type="pmid">19920054</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Usmanov</surname>
                      <given-names>RI</given-names>
                    </name>
                    <name>
                      <surname>Zueva</surname>
                      <given-names>EB</given-names>
                    </name>
                    <name>
                      <surname>Silverberg</surname>
                      <given-names>DS</given-names>
                    </name>
                    <name>
                      <surname>Shaked</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency</article-title>
                  <source>J Nephrol</source>
                  <year>2008</year>
                  <volume>21</volume>
                  <issue>2</issue>
                  <fpage>236</fpage>
                  <lpage>242</lpage>
                  <?supplied-pmid 18446719?>
                  <pub-id pub-id-type="pmid">18446719</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Munoz</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Breymann</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Garcia-Erce</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Gomez-Ramirez</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Comin</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Bisbe</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <article-title>Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion</article-title>
                  <source>Vox Sang</source>
                  <year>2008</year>
                  <volume>94</volume>
                  <issue>3</issue>
                  <fpage>172</fpage>
                  <lpage>183</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1423-0410.2007.01014.x</pub-id>
                  <?supplied-pmid 18069918?>
                  <pub-id pub-id-type="pmid">18069918</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mayhew</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Mendonca</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Murthy</surname>
                      <given-names>BVS</given-names>
                    </name>
                  </person-group>
                  <article-title>A review of ASA physical status—historical perspectives and modern developments</article-title>
                  <source>Anaesthesia</source>
                  <year>2019</year>
                  <volume>74</volume>
                  <issue>3</issue>
                  <fpage>373</fpage>
                  <lpage>379</lpage>
                  <pub-id pub-id-type="doi">10.1111/anae.14569</pub-id>
                  <?supplied-pmid 30648259?>
                  <pub-id pub-id-type="pmid">30648259</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>Practice guidelines for perioperative blood management</collab>
                  </person-group>
                  <article-title>an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management*</article-title>
                  <source>Anesthesiology</source>
                  <year>2015</year>
                  <volume>122</volume>
                  <issue>2</issue>
                  <fpage>241</fpage>
                  <lpage>275</lpage>
                  <pub-id pub-id-type="doi">10.1097/ALN.0000000000000463</pub-id>
                  <pub-id pub-id-type="pmid">25545654</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhou</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>A review of the application of autologous blood transfusion</article-title>
                  <source>Braz J Med Biol Res</source>
                  <year>2016</year>
                  <volume>49</volume>
                  <issue>9</issue>
                  <fpage>e5493</fpage>
                  <pub-id pub-id-type="doi">10.1590/1414-431x20165493</pub-id>
                  <?supplied-pmid 27533770?>
                  <pub-id pub-id-type="pmid">27533770</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Storch</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Custer</surname>
                      <given-names>BS</given-names>
                    </name>
                    <name>
                      <surname>Jacobs</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Menitove</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Mintz</surname>
                      <given-names>PD</given-names>
                    </name>
                  </person-group>
                  <article-title>Review of current transfusion therapy and blood banking practices</article-title>
                  <source>Blood Rev</source>
                  <year>2019</year>
                  <volume>38</volume>
                  <fpage>100593</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.blre.2019.100593</pub-id>
                  <?supplied-pmid 31405535?>
                  <pub-id pub-id-type="pmid">31405535</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhou</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Jin</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>QL</given-names>
                    </name>
                  </person-group>
                  <article-title>A study of preoperative autologous blood donation timing</article-title>
                  <source>Indian J Hematol Blood Transf</source>
                  <year>2018</year>
                  <volume>34</volume>
                  <issue>1</issue>
                  <fpage>138</fpage>
                  <lpage>142</lpage>
                  <pub-id pub-id-type="doi">10.1007/s12288-017-0842-8</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Park</surname>
                      <given-names>HJ</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>JU</given-names>
                    </name>
                    <name>
                      <surname>Yoo</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Moon</surname>
                      <given-names>YE</given-names>
                    </name>
                  </person-group>
                  <article-title>Analgesic effects of nefopam in patients undergoing bimaxillary osteotomy: a double-blind, randomized, placebo-controlled study</article-title>
                  <source>J Cranio-Maxillo-Facial Surg</source>
                  <year>2016</year>
                  <volume>44</volume>
                  <issue>2</issue>
                  <fpage>210</fpage>
                  <lpage>214</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jcms.2015.11.012</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Clavien</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Barkun</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>de Oliveira</surname>
                      <given-names>ML</given-names>
                    </name>
                    <name>
                      <surname>Vauthey</surname>
                      <given-names>JN</given-names>
                    </name>
                    <name>
                      <surname>Dindo</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Schulick</surname>
                      <given-names>RD</given-names>
                    </name>
                    <name>
                      <surname>de Santibañes</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Pekolj</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Slankamenac</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Bassi</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The Clavien–Dindo classification of surgical complications: five-year experience</article-title>
                  <source>Ann Surg</source>
                  <year>2009</year>
                  <volume>250</volume>
                  <issue>2</issue>
                  <fpage>187</fpage>
                  <lpage>196</lpage>
                  <pub-id pub-id-type="doi">10.1097/SLA.0b013e3181b13ca2</pub-id>
                  <?supplied-pmid 19638912?>
                  <pub-id pub-id-type="pmid">19638912</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Piaggio</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Elbourne</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Pocock</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Evans</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Altman</surname>
                      <given-names>DG</given-names>
                    </name>
                  </person-group>
                  <article-title>Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement</article-title>
                  <source>JAMA</source>
                  <year>2012</year>
                  <volume>308</volume>
                  <issue>24</issue>
                  <fpage>2594</fpage>
                  <lpage>2604</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2012.87802</pub-id>
                  <?supplied-pmid 23268518?>
                  <pub-id pub-id-type="pmid">23268518</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bonar</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Lippi</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Favaloro</surname>
                      <given-names>EJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Overview of hemostasis and thrombosis and contribution of laboratory testing to diagnosis and management of hemostasis and thrombosis disorders</article-title>
                  <source>Methods Mol Biol (Clifton)</source>
                  <year>2017</year>
                  <volume>1646</volume>
                  <fpage>3</fpage>
                  <lpage>27</lpage>
                  <pub-id pub-id-type="doi">10.1007/978-1-4939-7196-1_1</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bolger</surname>
                      <given-names>AP</given-names>
                    </name>
                    <name>
                      <surname>Bartlett</surname>
                      <given-names>FR</given-names>
                    </name>
                    <name>
                      <surname>Penston</surname>
                      <given-names>HS</given-names>
                    </name>
                    <name>
                      <surname>O'Leary</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Pollock</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Kaprielian</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Chapman</surname>
                      <given-names>CM</given-names>
                    </name>
                  </person-group>
                  <article-title>Intravenous iron alone for the treatment of anemia in patients with chronic heart failure</article-title>
                  <source>J Am Coll Cardiol</source>
                  <year>2006</year>
                  <volume>48</volume>
                  <issue>6</issue>
                  <fpage>1225</fpage>
                  <lpage>1227</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jacc.2006.07.015</pub-id>
                  <?supplied-pmid 16979010?>
                  <pub-id pub-id-type="pmid">16979010</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hogan</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Klein</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Richards</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>The impact of anaemia and intravenous iron replacement therapy on outcomes in cardiac surgery</article-title>
                  <source>Eur J Cardio-thoracic Surg</source>
                  <year>2015</year>
                  <volume>47</volume>
                  <issue>2</issue>
                  <fpage>218</fpage>
                  <lpage>226</lpage>
                  <pub-id pub-id-type="doi">10.1093/ejcts/ezu200</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Elhenawy</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Meyer</surname>
                      <given-names>SR</given-names>
                    </name>
                    <name>
                      <surname>Bagshaw</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>MacArthur</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Carroll</surname>
                      <given-names>LJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Role of preoperative intravenous iron therapy to correct anemia before major surgery: study protocol for systematic review and meta-analysis</article-title>
                  <source>Syst Rev</source>
                  <year>2015</year>
                  <volume>4</volume>
                  <fpage>29</fpage>
                  <pub-id pub-id-type="doi">10.1186/s13643-015-0016-4</pub-id>
                  <?supplied-pmid 25874460?>
                  <pub-id pub-id-type="pmid">25874460</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>YW</given-names>
                    </name>
                    <name>
                      <surname>Bae</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>YK</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>HK</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Yook</surname>
                      <given-names>JH</given-names>
                    </name>
                    <name>
                      <surname>Noh</surname>
                      <given-names>SH</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Ryu</surname>
                      <given-names>KW</given-names>
                    </name>
                    <name>
                      <surname>Sohn</surname>
                      <given-names>TS</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effect of intravenous ferric carboxymaltose on hemoglobin response among patients with acute isovolemic anemia following gastrectomy: The FAIRY randomized clinical trial</article-title>
                  <source>JAMA</source>
                  <year>2017</year>
                  <volume>317</volume>
                  <issue>20</issue>
                  <fpage>2097</fpage>
                  <lpage>2104</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2017.5703</pub-id>
                  <?supplied-pmid 28535237?>
                  <pub-id pub-id-type="pmid">28535237</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>van Iperen</surname>
                      <given-names>CE</given-names>
                    </name>
                    <name>
                      <surname>Gaillard</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Kraaijenhagen</surname>
                      <given-names>RJ</given-names>
                    </name>
                    <name>
                      <surname>Braam</surname>
                      <given-names>BG</given-names>
                    </name>
                    <name>
                      <surname>Marx</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>van de Wiel</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients</article-title>
                  <source>Crit Care Med</source>
                  <year>2000</year>
                  <volume>28</volume>
                  <issue>8</issue>
                  <fpage>2773</fpage>
                  <lpage>2778</lpage>
                  <pub-id pub-id-type="doi">10.1097/00003246-200008000-00015</pub-id>
                  <?supplied-pmid 10966249?>
                  <pub-id pub-id-type="pmid">10966249</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Roger</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Gaillard</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Bock</surname>
                      <given-names>AH</given-names>
                    </name>
                    <name>
                      <surname>Carrera</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Eckardt</surname>
                      <given-names>KU</given-names>
                    </name>
                    <name>
                      <surname>Van Wyck</surname>
                      <given-names>DB</given-names>
                    </name>
                    <name>
                      <surname>Cronin</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Meier</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Larroque</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Macdougall</surname>
                      <given-names>IC</given-names>
                    </name>
                  </person-group>
                  <article-title>Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial</article-title>
                  <source>Nephrol Dialysis Transpl</source>
                  <year>2017</year>
                  <volume>32</volume>
                  <issue>9</issue>
                  <fpage>1530</fpage>
                  <lpage>1539</lpage>
                  <pub-id pub-id-type="doi">10.1093/ndt/gfw264</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wolf</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Koch</surname>
                      <given-names>TA</given-names>
                    </name>
                    <name>
                      <surname>Bregman</surname>
                      <given-names>DB</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women</article-title>
                  <source>J Bone Min Res</source>
                  <year>2013</year>
                  <volume>28</volume>
                  <issue>8</issue>
                  <fpage>1793</fpage>
                  <lpage>1803</lpage>
                  <pub-id pub-id-type="doi">10.1002/jbmr.1923</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cada</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Levien</surname>
                      <given-names>TL</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>DE</given-names>
                    </name>
                  </person-group>
                  <article-title>Ferric carboxymaltose</article-title>
                  <source>Hosp Pharm</source>
                  <year>2014</year>
                  <volume>49</volume>
                  <issue>1</issue>
                  <fpage>52</fpage>
                  <lpage>59</lpage>
                  <pub-id pub-id-type="doi">10.1310/hpj4901-52</pub-id>
                  <?supplied-pmid 24421564?>
                  <pub-id pub-id-type="pmid">24421564</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oh</surname>
                      <given-names>AY</given-names>
                    </name>
                    <name>
                      <surname>Seo</surname>
                      <given-names>KS</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>GE</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>HJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of preoperative autologous blood donation on patients undergoing bimaxillary orthognathic surgery: a retrospective analysis</article-title>
                  <source>Int J Oral Maxillofac Surg</source>
                  <year>2016</year>
                  <volume>45</volume>
                  <issue>4</issue>
                  <fpage>486</fpage>
                  <lpage>489</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ijom.2015.11.008</pub-id>
                  <?supplied-pmid 26678802?>
                  <pub-id pub-id-type="pmid">26678802</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lahsaee</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Ghaffaripour</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hejr</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>The effect of routine maintenance intravenous therapy on hemoglobin concentration and hematocrit during anesthesia in adults</article-title>
                  <source>Bull Emerg Trauma</source>
                  <year>2013</year>
                  <volume>1</volume>
                  <issue>3</issue>
                  <fpage>102</fpage>
                  <lpage>107</lpage>
                  <?supplied-pmid 27162835?>
                  <pub-id pub-id-type="pmid">27162835</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kretschmer</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Koster</surname>
                      <given-names>U</given-names>
                    </name>
                    <name>
                      <surname>Dietz</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Zoder</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Wangerin</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>Factors for intraoperative blood loss in bimaxillary osteotomies</article-title>
                  <source>J Oral Maxillofac Surg</source>
                  <year>2008</year>
                  <volume>66</volume>
                  <issue>7</issue>
                  <fpage>1399</fpage>
                  <lpage>1403</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.joms.2008.01.060</pub-id>
                  <?supplied-pmid 18571023?>
                  <pub-id pub-id-type="pmid">18571023</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gell</surname>
                      <given-names>DA</given-names>
                    </name>
                  </person-group>
                  <article-title>Structure and function of haemoglobins</article-title>
                  <source>Blood Cells Mol Dis</source>
                  <year>2018</year>
                  <volume>70</volume>
                  <fpage>13</fpage>
                  <lpage>42</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bcmd.2017.10.006</pub-id>
                  <?supplied-pmid 29126700?>
                  <pub-id pub-id-type="pmid">29126700</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Long</surname>
                      <given-names>MY</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>ZH</given-names>
                    </name>
                    <name>
                      <surname>Zhu</surname>
                      <given-names>JG</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparative analysis of autologous blood transfusion and allogeneic blood transfusion in surgical patients</article-title>
                  <source>Int J Clin Exp Med</source>
                  <year>2014</year>
                  <volume>7</volume>
                  <issue>9</issue>
                  <fpage>2889</fpage>
                  <lpage>2894</lpage>
                  <?supplied-pmid 25356154?>
                  <pub-id pub-id-type="pmid">25356154</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jakovina Blazekovic</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Bicanic</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Hrabac</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Tripkovic</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Delimar</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>Pre-operative autologous blood donation versus no blood donation in total knee arthroplasty: a prospective randomised trial</article-title>
                  <source>Int Orthop</source>
                  <year>2014</year>
                  <volume>38</volume>
                  <issue>2</issue>
                  <fpage>341</fpage>
                  <lpage>346</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00264-013-2185-x</pub-id>
                  <?supplied-pmid 24305788?>
                  <pub-id pub-id-type="pmid">24305788</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Spinella</surname>
                      <given-names>PC</given-names>
                    </name>
                    <name>
                      <surname>Cap</surname>
                      <given-names>AP</given-names>
                    </name>
                  </person-group>
                  <article-title>Whole blood: back to the future</article-title>
                  <source>Curr Opin Hematol</source>
                  <year>2016</year>
                  <volume>23</volume>
                  <issue>6</issue>
                  <fpage>536</fpage>
                  <lpage>542</lpage>
                  <pub-id pub-id-type="doi">10.1097/MOH.0000000000000284</pub-id>
                  <?supplied-pmid 27607444?>
                  <pub-id pub-id-type="pmid">27607444</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Walunj</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Babb</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Sharpe</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Autologous blood transfusion</article-title>
                  <source>Continuing Educ Anaesth Crit Care Pain</source>
                  <year>2006</year>
                  <volume>6</volume>
                  <issue>5</issue>
                  <fpage>192</fpage>
                  <lpage>196</lpage>
                  <pub-id pub-id-type="doi">10.1093/bjaceaccp/mkl042</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lee</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <name>
                      <surname>Song</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Jung</surname>
                      <given-names>YS</given-names>
                    </name>
                    <name>
                      <surname>Koo</surname>
                      <given-names>BN</given-names>
                    </name>
                  </person-group>
                  <article-title>A randomised trial evaluating the effect of intraoperative iron administration</article-title>
                  <source>Sci Rep</source>
                  <year>2020</year>
                  <volume>10</volume>
                  <issue>1</issue>
                  <fpage>15853</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-020-72827-5</pub-id>
                  <?supplied-pmid 32985539?>
                  <pub-id pub-id-type="pmid">32985539</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
